Ben Blount (Synthetic Genomics; Yeast Synthetic Biology; DNA Assembly; Glycoengineering; Genome Design). My research focuses on developing advanced magnetic resonance imaging (MRI) methods to measure human brain physiology non invasively. I concentrate on imaging aspects of brain function that are otherwise difficult to capture, particularly oxygen metabolism, cerebrovascular reactivity and cerebral blood volume.
Boyan Bonev (Structural biology; computational biology; biophysics; NMR; membrane proteins; membrane lipids; AMR; bacterial physiology; solvent tolerant bacteria; antimicrobial drug design). Research in the Bonev lab is focused on the study of the organisation and composition of cell membranes, the interfaces of life, to understand their compositional variation and stability. Primary tools include solid state NMR (Nuclear Magnetic Resonance), molecular dynamics simulations and other advanced biophysical and computational techniques. The team is interested in the molecular mechanisms of infection and resistance to antibiotics. To understand and tackle bacteria, resistant to antibiotics, they study bacterial physiology and specific molecular targets, which they use to develop new approaches for antimicrobial intervention and bacterial control. Work is funded primarily by the UK Biotechnology and Biological Sciences Research Council (BBSRC), as well as the Medical Research Council (MRC) and the Engineering and Physical Sciences Research Council (EPSRC).
William Brown (Chromosome biology).
Ruth Griffin (Mucosal vaccines, platform delivery technologies, infectious diseases, bacterial pathogens, antimicrobial peptides).
John Heap (Synthetic biology).
Klaus Winzer (Bacteria, Metabolism, Physiology, Biochemistry, Fermentation, Metabolic Engineering, Biological Engineering).
Ying Zhang (strain engineering; bioproducts from renewable sources; synthetic biology approaches to generate novel strains with advanced properties; synthetic bioactive peptides/protein).
Biotechnology Supervisors
Ed Bolt (CRISPR Biology & Biotechnology, DNA repair, Homologous Recombination)
Matthias Brock (Fungi, Metabolism, Fungal Infections, Therapy, neutral Products, Biotechnology, Synthetic Biology)
Paul Dyer (Fungal Biology, Food Mycology, Genetics, Genomics, Mould-ripened Cheese)
John Heap (Biotechnology).
Yan Liao My research focuses on understanding the molecular mechanisms that archaeal cells use for adaptation, interaction, and division, and on developing these systems for novel biotechnological applications relevant to environmental and human health.
Babatunde Okesola (Biomaterials, self-assembling materials, hydrogel technology, immune-instructive, redox biology, peptides design, nanomedicine, regenerative medicine). My research focuses on the design and translation of advanced biomaterials for applications in regenerative medicine and nanomedicine, with particular emphasis on self-assembling materials, nanozymes and hydrogel technology. I develop bioinspired material systems that mimic key aspects of the cellular microenvironment to regulate tissue repair, immune responses, and cellular function. By integrating principles from peptide design, nanotechnology, materials science, and cell biology, my work aims to create dynamic and tuneable biomaterials capable of guiding biological processes in a controlled manner.
Michael Okun (Systems and computational neuroscience, high-density in vivo electrophysiology, action of psychedelic drugs). Our laboratory is interested in cortical circuit dynamics, particularly in the spontaneous activity regime and over long timescales. Our lab employs electrophysiological and computational methods to explore the activity of individual neurons and neuronal populations in normal conditions and under the influence of psychoactive compounds.
Uwe Vinkemeier (Neuroimmunology and cytokine-regulation of STAT transcriptional activity in the immune system).
糖心原创Medical School Queen's Medical CentreNottingham NG7 2UH
e: life-sciences@nottingham.ac.uk t: +44 (0)115 823 0141 f: +44 (0)115 823 0142